While it has not received FDA approval for therapeutic use, it is available for research purposes and is used in metabolic optimization protocols
Notably, animal models have demonstrated that transferring dysbiotic microbiota from CFS/ME patients to germ-free mice can induce fatigue-like behaviors, supporting a causal role for the microbiome in disease pathogenesis ( 3.5.4 Gut microbiota-based therapeutic interventions 3.5.4.1 Probiotics Given these findings, probiotic supplementation, particularly with strains of Lactobacillus and Bifidobacterium , has shown potential to restore microbial balance, enhance SCFA production, and reduce inflammation in CFS/ME patients (Carrasco-Querol et al., 2024
Efficacy of bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis
The complete reconstitution guide provides additional detail on this process for various peptide types
[DOI] [Google Scholar] 30.Ren X., Zou L., Zhang X., Branco V., Wang J., Carvalho C., Holmgren A., Lu J